Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Fischer Chemic
Join Channel
Consolidated Standalone

Fischer Medical

₹537.8 15.8 | 3%

Market Cap ₹2877 Cr.

Stock P/E -167.7

P/B 36.8

Current Price ₹537.8

Book Value ₹ 14.6

Face Value 10

52W High ₹702.4

Dividend Yield 0%

52W Low ₹ 66.8

Edit Ratio

Fischer Medical Research see more...

Overview Inc. Year: 1993Industry: Chemicals

Fischer Chemic Ltd provides consultancy services in India. Its activities also include AMC services. The agency incorporated in 1993 and is based in Mumbai, India.

Read More..

Fischer Medical Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Fischer Medical Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
Operating Profit -0 -0 -0 -0 -0 -0 -0 -0 0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 -0 -0 -0 -0 -0 -0 0 -0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 -0 -0 -0 -0 -0 -0 -0 0 -0
Adjustments 0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments -0 -0 -0 -0 -0 -0 -0 -0 0 -0
Adjusted Earnings Per Share -2.7 -4.1 -3.4 -3.5 -3.3 -3.4 -2.4 -0.9 0.6 -0.5

Fischer Medical Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1 0 0 0 0 0 0 0 0 0 0 0
Other Income 3 0 0 0 0 0 0 0 0 0 0 0
Total Income 4 0 0 0 0 0 0 0 0 0 0 0
Total Expenditure 3 0 0 0 0 0 0 0 0 0 0 0
Operating Profit 1 0 0 -0 -0 0 0 -0 -0 -0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 0 -0 -0 0 0 -0 -0 -0 -0 0
Provision for Tax -0 0 0 0 0 0 0 0 -0 0 0 0
Profit After Tax 1 0 0 -0 -0 0 0 -0 0 -0 -0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 0 0 -0 -0 0 0 -0 0 -0 -0 0
Adjusted Earnings Per Share 3.8 0 0.1 -0.1 -0.2 0.1 0.3 -2.4 8.2 -13.5 -2.1 -3.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% -100%
Operating Profit CAGR 0% 0% 0% -100%
PAT CAGR 0% 0% 0% -100%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 369% 176% 43% 67%
ROE Average 0% 0% 0% 0%
ROCE Average 7% -33% -24% -452%

Fischer Medical Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds -0 -0 -0 -0 -0 -0 -0 -0 0 -0 -0
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 -0 -0 -0
Total Current Liabilities 0 0 0 0 0 0 0 0 0 0 1
Total Liabilities 0 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 0 0 0 0 0 0 0 0 0 0 0

Fischer Medical Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 1 -0 0 -0 -0 -0 0 0 -0 -0 -0
Cash Flow from Investing Activities 2 0 0 0 0 0 0 0 0 0 0
Cash Flow from Financing Activities -3 -0 -0 0 0 0 -0 0 -0 0 0
Net Cash Inflow / Outflow -0 -0 0 -0 0 0 -0 0 -0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Fischer Medical Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 3.81 0.01 0.08 -0.1 -0.19 0.07 0.26 -2.39 8.17 -13.52 -2.12
CEPS(Rs) 4.37 0.01 0.08 -0.1 -0.19 0.07 0.26 -2.39 8.17 -13.52 -2.12
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) -0.09 -0.09 -0.01 -0.1 -0.3 -5.87 -5.61 -7.99 0.18 -13.34 -15.47
Core EBITDA Margin(%) -311.86 -141.17 -315.19 0 0 0 0 -12.52 -10.67 0 8.47
EBIT Margin(%) 164.36 10.36 134.68 0 0 0 0 -12.52 -10.67 0 8.47
Pre Tax Margin(%) 162.43 10.09 134.53 0 0 0 0 -22.31 -21.58 0 -0.72
PAT Margin (%) 202.09 10.09 134.53 0 0 0 0 -22.31 85.21 0 -20.33
Cash Profit Margin (%) 231.62 10.09 134.53 0 0 0 0 -22.31 85.21 0 -20.33
ROA(%) 41.69 1.96 126.42 -146.97 -226.65 1.24 3.55 -32.81 130.63 -367.17 -24.56
ROE(%) 0 0 0 0 0 0 0 0 0 0 0
ROCE(%) 246.28 10.51 0 -4751.97 -358.43 1.67 4.75 -25.27 -11.19 -95.4 6.53
Receivable days 196.27 0 0 0 0 0 0 0 0 0 346.9
Inventory Days 231.5 0 0 0 0 0 0 0 0 0 0
Payable days 46.99 0 0 0 0 0 0 0 0 0 0
PER(x) 0.97 281.54 47.5 0 0 210.55 222.41 0 3.12 0 0
Price/Book(x) -39.17 -42.72 -474.85 -19.73 -6.43 -2.34 -10.46 -6.21 141.48 -5.85 -5.43
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 2.02 28.46 62.9 0 0 0 0 5.26 3.8 0 11.03
EV/Core EBITDA(x) 1.04 274.84 46.7 -22.34 -11.46 250.26 198.24 -41.98 -35.6 -9.09 130.31
Net Sales Growth(%) -60.21 -93.19 -54.96 -100 0 0 0 0 -10.28 -100 0
EBIT Growth(%) 287.09 -99.57 485.8 -223.59 -99.74 102.1 305.5 -508.59 23.57 -972.16 108.06
PAT Growth(%) 334.42 -99.66 500.64 -224.08 -99.16 101.7 303.16 -1004.54 442.71 -265.43 84.31
EPS Growth(%) 334.42 -99.66 499.23 -224.06 -99.16 133.98 303.21 -1004.56 442.7 -265.43 84.31
Debt/Equity(x) -4.09 -0.56 0 -1.11 -1.32 -2.33 -2.07 -1.57 75.1 -1.7 -2.15
Current Ratio(x) 1.25 0.57 0.9 1.25 6.99 15.57 12.95 2.33 4.37 0.12 0.4
Quick Ratio(x) 1.2 0.57 0.9 1.25 6.99 15.57 12.95 2.33 4.37 0.12 0.4
Interest Cover(x) 85.17 38.83 931.28 -342.79 0 0 0 -1.28 -0.98 -21.69 0.92
Total Debt/Mcap(x) 0.1 0.01 0 0.06 0.21 0.99 0.2 0.25 0.53 0.29 0.4

Fischer Medical Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 0 0 0 0 0 0 0 0 0 0
FII 0 0 0 0 0 0 0 0 0 5.07
DII 0 0 0 0 0 0 0 0 0 1.68
Public 100 100 100 100 100 100 100 100 100 93.24
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of 0% over the last 3 years.
  • Stock is trading at 36.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Fischer Medical News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!